MX9306016A - Metodo para incrementar respuestas inmunes mediadas por celulas. - Google Patents

Metodo para incrementar respuestas inmunes mediadas por celulas.

Info

Publication number
MX9306016A
MX9306016A MX9306016A MX9306016A MX9306016A MX 9306016 A MX9306016 A MX 9306016A MX 9306016 A MX9306016 A MX 9306016A MX 9306016 A MX9306016 A MX 9306016A MX 9306016 A MX9306016 A MX 9306016A
Authority
MX
Mexico
Prior art keywords
cells
immune responses
responses mediated
increase immune
immunogen
Prior art date
Application number
MX9306016A
Other languages
English (en)
Inventor
Balbir S Bhogal
Krishnaswamy I Dayalu
Jay D Gerber
Original Assignee
Smithkline Beechman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beechman Corp filed Critical Smithkline Beechman Corp
Publication of MX9306016A publication Critical patent/MX9306016A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)

Abstract

Un método para incrementar una respuesta inmune mediada por célulasespecíficas, preferiblemente en cerdos, que incluye vacunar a animaleshembras con un inmunógeno de Mycoplasma, de modo que la vacunaciónsubsecuente del recién nacido con el mismo inmunógeno estimula unarespuesta inmune mediada por células en comparación con recién nacidos demadres no vacunadas.
MX9306016A 1992-09-28 1993-09-28 Metodo para incrementar respuestas inmunes mediadas por celulas. MX9306016A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95224892A 1992-09-28 1992-09-28

Publications (1)

Publication Number Publication Date
MX9306016A true MX9306016A (es) 1995-01-31

Family

ID=25492700

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9306016A MX9306016A (es) 1992-09-28 1993-09-28 Metodo para incrementar respuestas inmunes mediadas por celulas.

Country Status (11)

Country Link
EP (1) EP0839050B1 (es)
JP (1) JPH08502253A (es)
AT (1) ATE273022T1 (es)
AU (1) AU687750B2 (es)
CA (1) CA2145760A1 (es)
DE (1) DE69333588T2 (es)
DK (1) DK0839050T3 (es)
ES (1) ES2225825T3 (es)
MX (1) MX9306016A (es)
PT (1) PT839050E (es)
WO (1) WO1994007531A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6620300A (en) 1999-08-03 2001-02-19 Ohio State University, The Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
CZ305781B6 (cs) 2001-07-02 2016-03-16 Zoetis Services Llc Výroba vakcíny Mycoplasma hyopneumoniae
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
WO2006138675A2 (en) 2005-06-15 2006-12-28 The Ohio State University Research Foundation Her-2 peptides
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US8398970B2 (en) 2007-09-17 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early Lawsonia intracellularis infections
US20100234283A1 (en) 2009-02-04 2010-09-16 The Ohio State University Research Foundation Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use
DK2569007T3 (en) 2010-05-11 2016-01-25 Intervet Int Bv VACCINE AGAINST Mycoplasma hyopneumoniae SUITABLE FOR ADMINISTRATION IN PRESENCE OF maternally derived antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US4985243A (en) * 1988-01-20 1991-01-15 Ml Technology Ventures, L.P. Composition and method for protecting against diseases caused by microorganisms
US4981684A (en) * 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
JP3187419B2 (ja) * 1990-05-29 2001-07-11 アメリカン・サイアナミド・カンパニー ブタ肺炎ワクチンおよびその製造方法
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof

Also Published As

Publication number Publication date
ES2225825T3 (es) 2005-03-16
JPH08502253A (ja) 1996-03-12
DE69333588D1 (de) 2004-09-16
EP0839050B1 (en) 2004-08-11
ATE273022T1 (de) 2004-08-15
CA2145760A1 (en) 1994-04-14
WO1994007531A1 (en) 1994-04-14
AU4931293A (en) 1994-04-26
PT839050E (pt) 2004-11-30
DK0839050T3 (da) 2004-10-25
EP0839050A4 (es) 1998-05-06
DE69333588T2 (de) 2005-08-04
AU687750B2 (en) 1998-03-05
EP0839050A1 (en) 1998-05-06

Similar Documents

Publication Publication Date Title
EP0438803A3 (en) Vaccines against cancer and infectious diseases
MX9306841A (es) Vacuna a base de ureasa contra la infeccion por helicobacter en mamiferos.
DK0714444T3 (da) Dæmpning af en immundominant epitop i et antigen til anvendelse i plante-, dyre- og humanvacciner og immunbehandlinger
ES2152421T3 (es) Vacunas de conjugados polisacarido neumococcico-neumolisina recombinante para la inmunizacion contra las infecciones neumococcicas.
IE871003L (en) Vaccine.
DE3486293D1 (de) Impfstoff-Zubereitung.
BR9106748A (pt) Vacina de hyopneumomiae micoplasma inativado e metodo de seu uso
DK450183A (da) Humane monoklone antistoffer mod et bakterietoksin samt disses fremstilling, kontinuerlige cellelinier, som producerer antitoksin-antistoffer, samt antistoffernes anvendelser
NO950739D0 (no) Vaksiner mot gruppe C Neisseria Meningtidis
ES537459A0 (es) Procedimiento para preparar anticuerpos anti-idiotipicos
MX9306016A (es) Metodo para incrementar respuestas inmunes mediadas por celulas.
DE68929318T2 (de) Legionellosis-Impfstoffe und Verfahren zur deren Herstellung
DK341679A (da) Vaccine mod streptokokker og fremgangsmaade til fremstilling deraf
Ekunwe Expanding immunization coverage through improved clinic procedures.
ATE109004T1 (de) Toleranzinduktion gegenüber einem fremdantigen.
BR9306187A (pt) Vacina bacterin-toxóide pasteurella haemolytica tipo a-1
Toma et al. Vaccination of dogs against rabies. Comparison of serological responses one year after intradermal or subcutaneous vaccination
ES2059605T3 (es) Vacuna toxoide de la tosferina.
Kraaijeveld et al. Delayed type hypersensitivity against semliki forest virus in mice: local transfer of delayed type hypersensitivity with thioglycollate-induced peritoneal exudate cells
NZ212274A (en) Method of producing anti-male antibodies, antibodies so produced and lymphocytes
Zheng et al. Studies on the biological properties of a chemical vaccine prepared from antigenic fractions of Vibrio cholerae.
Wang Studies on the biological properties of avirulent Rickettsia prowazekii Madrid E.
Dong et al. Preparation of various cholera vaccines and comparison of their immuno-effect.
JPS6423893A (en) Method for cell fusion